FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37405499> ?p ?o ?g. }

• Q37405499 description "article científic" @default.
• Q37405499 description "article scientifique" @default.
• Q37405499 description "articolo scientifico" @default.
• Q37405499 description "artigo científico" @default.
• Q37405499 description "artículu científicu espublizáu en 2008" @default.
• Q37405499 description "bilimsel makale" @default.
• Q37405499 description "scientific article published on 02 February 2008" @default.
• Q37405499 description "vedecký článok" @default.
• Q37405499 description "vetenskaplig artikel" @default.
• Q37405499 description "videnskabelig artikel" @default.
• Q37405499 description "vědecký článek" @default.
• Q37405499 description "wetenschappelijk artikel" @default.
• Q37405499 description "wissenschaftlicher Artikel" @default.
• Q37405499 description "наукова стаття, опублікована в лютому 2008" @default.
• Q37405499 description "научни чланак" @default.
• Q37405499 description "مقالة علمية نشرت في 02 فبراير 2008" @default.
• Q37405499 name "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 name "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 name "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 type Item @default.
• Q37405499 label "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 label "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 label "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 prefLabel "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 prefLabel "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 prefLabel "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin." @default.
• Q37405499 P1433 Q37405499-97F56942-7924-41A1-B68F-192C01C361DF @default.
• Q37405499 P1476 Q37405499-B2312051-5FB7-42D8-9886-6040CFEDCF25 @default.
• Q37405499 P2093 Q37405499-548BBDF6-3F7B-43FB-86AE-4F1AF20B08DC @default.
• Q37405499 P2093 Q37405499-EE88106F-B3E7-438C-8CD7-E68CAB22DB98 @default.
• Q37405499 P2860 Q37405499-1136392C-EE55-45D2-8C13-A09641DA579C @default.
• Q37405499 P2860 Q37405499-1382819B-45D6-4748-8B23-BA1F2F5D22E8 @default.
• Q37405499 P2860 Q37405499-160E62E5-973D-4327-8072-B70AE96154AF @default.
• Q37405499 P2860 Q37405499-23888FFB-F2F6-4012-B810-09A8C3759C50 @default.
• Q37405499 P2860 Q37405499-2FDB04CC-B1B8-4E83-9E2B-CE73899897F5 @default.
• Q37405499 P2860 Q37405499-30958D80-C4CA-45BB-BA79-5268A32F9974 @default.
• Q37405499 P2860 Q37405499-3F5CE623-F112-4EF5-9DC8-238B1DF922AA @default.
• Q37405499 P2860 Q37405499-3F84F577-D614-4087-808D-15428506D115 @default.
• Q37405499 P2860 Q37405499-41FB9BDF-CD3F-44E4-81CA-26B6988492B2 @default.
• Q37405499 P2860 Q37405499-4642E6DE-D7AD-4E97-8EC0-E1A2C770BE7D @default.
• Q37405499 P2860 Q37405499-4E274D49-C455-451D-9CB6-72293CA9C890 @default.
• Q37405499 P2860 Q37405499-506B4633-924F-4018-AED1-4A48D2864ED2 @default.
• Q37405499 P2860 Q37405499-54CBDAA6-EC96-4A22-97D4-2DA89043956C @default.
• Q37405499 P2860 Q37405499-563E53F4-72B4-481E-B4A9-AE951DD960E1 @default.
• Q37405499 P2860 Q37405499-56D069AD-FE28-42B3-96F0-0D5AEDC2CDB4 @default.
• Q37405499 P2860 Q37405499-5D67FFFD-964D-418F-95AD-38EEDFFAD2D0 @default.
• Q37405499 P2860 Q37405499-6149D257-D9BA-4488-A3B6-44B89F6EC14B @default.
• Q37405499 P2860 Q37405499-6899ADCE-AD40-4503-B979-EB6AD403CAAD @default.
• Q37405499 P2860 Q37405499-68CE3935-2817-45B0-85F4-C3E4867567C7 @default.
• Q37405499 P2860 Q37405499-75E76B0E-1BAE-4634-9A8F-ECD02497CCAE @default.
• Q37405499 P2860 Q37405499-773C36B5-AE21-4E84-B288-A95EC417AB08 @default.
• Q37405499 P2860 Q37405499-7DB13F46-E285-4BBC-9FEF-35B6843A3A7C @default.
• Q37405499 P2860 Q37405499-7F1B0E4A-9477-4925-AEBF-B26AA2AB4D4B @default.
• Q37405499 P2860 Q37405499-80029AFE-9996-4331-90B6-9B82CEE4A46B @default.
• Q37405499 P2860 Q37405499-845B5611-9F39-489A-AD1B-432BA828384D @default.
• Q37405499 P2860 Q37405499-85694730-7028-460A-BC5C-2914DB122E77 @default.
• Q37405499 P2860 Q37405499-905F3918-1AF9-4D8B-99D7-4178E9065DF9 @default.
• Q37405499 P2860 Q37405499-9BD16854-D688-4FD9-AAF4-D8512E2902FD @default.
• Q37405499 P2860 Q37405499-9ED8FFDE-669E-415E-B9E8-7046C090413C @default.
• Q37405499 P2860 Q37405499-A0B4E049-2ED0-4A69-96B5-175CC79A7732 @default.
• Q37405499 P2860 Q37405499-A197FA61-22A9-4702-8042-BA28C84DECE2 @default.
• Q37405499 P2860 Q37405499-A77FF138-0EB4-4E46-B8F7-E02B86180C67 @default.
• Q37405499 P2860 Q37405499-AE2FE7CA-052C-42ED-A056-D248EAF69EE3 @default.
• Q37405499 P2860 Q37405499-BE3FFBF3-76D6-416C-A538-63DE998A37F0 @default.
• Q37405499 P2860 Q37405499-CD64BAF1-B8D2-4B56-A927-7326A85C87F4 @default.
• Q37405499 P2860 Q37405499-D066DD92-0955-4165-8D42-5B4B7B8DBE9D @default.
• Q37405499 P2860 Q37405499-D27DB5DA-4D92-4A31-8310-67861E894E89 @default.
• Q37405499 P2860 Q37405499-DC18089A-4B1C-4CDA-ABED-098ED84ABD38 @default.
• Q37405499 P2860 Q37405499-DCA22AF4-4D0D-40B2-91E1-7EC40EEA7698 @default.
• Q37405499 P2860 Q37405499-DFD4F9E3-094B-4592-A813-24DB8C12F9AA @default.
• Q37405499 P2860 Q37405499-E1E41E24-9E0A-4EF3-994C-05BD2710A6EE @default.
• Q37405499 P2860 Q37405499-E5E3E0A8-1C18-4838-90AA-BAA3826364DC @default.
• Q37405499 P2860 Q37405499-E83BC668-0766-4F14-85F2-FDB8A76647B3 @default.
• Q37405499 P2860 Q37405499-EC40DA8E-296B-4105-B347-A0ADCFB494DD @default.
• Q37405499 P2860 Q37405499-F3EAAAC7-F424-45B9-A8FF-E6E9C50D8A36 @default.
• Q37405499 P2860 Q37405499-F4132613-7E36-46CA-A539-D0ED59BDCEEE @default.
• Q37405499 P2860 Q37405499-F4A7B316-0BD9-48DB-A757-52DD49EB9AB2 @default.
• Q37405499 P2860 Q37405499-F7A24B07-C456-48F9-9958-DEA724153E10 @default.
• Q37405499 P2860 Q37405499-FA3C57C8-8E39-4EF2-998F-B5BD098E7CDC @default.
• Q37405499 P2860 Q37405499-FAEAAED1-FCEC-4A5B-B96F-39F2EF6CF53A @default.
• Q37405499 P304 Q37405499-2BAE59DB-CECB-4008-98BD-41EB141D5034 @default.
• Q37405499 P31 Q37405499-0EA93BAB-E9FA-47DC-9AFC-566917C42457 @default.
• Q37405499 P31 Q37405499-df256eb4-187c-41c1-9e44-310e5bb1ea3d @default.
• Q37405499 P356 Q37405499-6D29A8F4-093E-4DC6-9C9D-AAD8B829DE0B @default.
• Q37405499 P407 Q37405499-9E87A081-6E66-4862-B9B3-63BBEAC5F442 @default.
• Q37405499 P478 Q37405499-6E0C8D98-5D09-46E4-94A7-EFD8AFC1015E @default.
• Q37405499 P577 Q37405499-C086C2BE-C555-4CE4-A2F6-D011F757C0FF @default.
• Q37405499 P698 Q37405499-9CD87A65-2008-46A6-82BB-B39860789AE4 @default.
• Q37405499 P932 Q37405499-F1FBD764-53CD-4592-9DCA-4898D4AA1193 @default.
• Q37405499 P356 PPA.S3417 @default.
• Q37405499 P698 19920982 @default.
• Q37405499 P1433 Q7144972 @default.
• Q37405499 P1476 "Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin" @default.
• Q37405499 P2093 "Peter Sand" @default.
• Q37405499 P2093 "Tondalaya Gamble" @default.
• Q37405499 P2860 Q28202479 @default.
• Q37405499 P2860 Q33253882 @default.
• Q37405499 P2860 Q33778812 @default.
• Q37405499 P2860 Q33892704 @default.
• Q37405499 P2860 Q34142781 @default.

• next